You are here
The medical industry is supportive of the mission and initiatives of the Society for Vascular Surgery (SVS). Corporations partner with SVS to advance the care of vascular patients through support of the Society's meetings, events, and initiatives. Support of SVS programming and services provides a unique and valued opportunity to establish companies as an integral part of the vascular health community.
Partners are acknowledged through a recognition program that provides exposure, extends the corporate message, and builds loyalty among vascular surgeons.
Thank you to SVS Corporate Partners
The Society for Vascular Surgery would like to thank the following companies for their support of the Vascular Annual Meeting and participation in the SVS Corporate Partners Program.
2015 SVS Corporate Contributors
The following are SVS corporate contributors for the April 1, 2014 - March 31, 2015 fiscal year:
- Abbott Vascular ($100,000)
- Argon Medical ($7,500)
- Bard Peripheral Vascular ($15,000)
- Bloxr Corporation ($2,000)
- Bolton Medical ($40,000)
- Boston Scientific ($100,000)
- Bristol-Meyers Squibb/Sanofi-Aventis ($10,000)
- Cook Medical, Inc. ($125,000)
- Cordis Corporation ($40,000)
- Covidien ($65,000)
- Endologix, Inc. ($20,000)
- Gore & Associates ($260,000)
- Medtronic ($355,000)
- Sapheon Inc. ($10,000)
Twenty six percent of SVS operating revenue for the fiscal year ending March 31, 2015 was derived from industry support. Sixteen percent was from industry support for education, research, and the PSO; the remaining 10 percent was from industry exhibits and advertising at the Vascular Annual Meeting.
For more information see sponsorship opportunities and review the Guidelines for SVS Management of Relationships with Industry.